Results 201 to 210 of about 6,048,033 (361)
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner+6 more
wiley +1 more source
Chemistry-informed recommender system to predict optimal molecular receptors in SERS nanosensors. [PDF]
Tan EX+5 more
europepmc +1 more source
Infra-red Receptors in Melanophila acuminata DeGeer [PDF]
William G. Evans
openalex +1 more source
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul+11 more
wiley +1 more source
Using the PET/CT radiotracer [68Ga]Ga-DOTA-mDesmo to target V1b receptors and localize corticotropinoma in Cushing's disease. [PDF]
Pandey S+8 more
europepmc +1 more source
INFLUENCE OF ADRENERGIC BETA‐RECEPTOR BLOCKADE ON THE ACUTE CARDIOVASCULAR EFFECTS OF HYDRALAZINE* [PDF]
H. Brünner, P. R. Hedwall, Max Meier
openalex +1 more source
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva+5 more
wiley +1 more source
THE ROLE OF IONIC INTERACTION AT THE MUSCARINIC RECEPTOR [PDF]
A. S. V. Burgen
openalex +1 more source